| MCVIX | VEVYX | MCVIX / VEVYX | |
| Total Expense Ratio | 0.72 | 0.66 | 109% |
| Annual Report Gross Expense Ratio | 0.73 | 0.66 | 111% |
| Fund Existence | 25 years | 13 years | - |
| Gain YTD | 13.306 | 14.165 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.2B | 15.3B | 112% |
| Annual Yield % from dividends | 1.28 | 1.11 | 115% |
| Returns for 1 year | 10.01 | 10.65 | 94% |
| Returns for 3 years | 21.64 | 13.06 | 166% |
| Returns for 5 years | 19.80 | 10.07 | 197% |
| Returns for 10 years | 88.29 | 68.40 | 129% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFIX | 18.74 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare I | |||
| VZICX | 38.53 | N/A | N/A |
| Vanguard International Core Stock Adm | |||
| SINAX | 43.65 | N/A | N/A |
| ClearBridge Large Cap Value A | |||
| KMKCX | 77.06 | N/A | N/A |
| Kinetics Market Opportunities Adv C | |||
| LICOX | 21.55 | N/A | N/A |
| Lord Abbett International Equity F3 | |||